Samsung Biologics Co., Ltd. is a key player in the biopharmaceutical manufacturing and services industry. Established as a subsidiary of Samsung Group, it focuses on the development and manufacturing ... Samsung Biologics Co., Ltd. is a key player in the biopharmaceutical manufacturing and services industry. Established as a subsidiary of Samsung Group, it focuses on the development and manufacturing of biologic drugs. The company provides contract development and manufacturing organization (CDMO) services, supporting pharmaceutical companies in bringing innovative treatments to market efficiently. Samsung Biologics operates through state-of-the-art facilities offering comprehensive services from cell line development to large-scale manufacturing, impacting the healthcare and biotechnology sectors significantly. Headquartered in South Korea, it plays a critical role in the global supply chain of biologics, an essential component in treating complex diseases like cancer and autoimmune disorders. The company's strategic partnerships and investments in advanced bioprocessing technologies enhance its market position as a leader in its field.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Samsung Biologics is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Samsung Biologics is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Samsung Biologics's data?

Start your 30-day free trial to request a data review for Samsung Biologics.

Start Free Trial

Legal Center Contact Us